Which has the lower trailing P/E, BIIB or GEHC?

GEHC has the lower trailing P/E: BIIB trades at 40.28 and GEHC at 19.31. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or GEHC?

Over the past five years, GEHC grew revenue faster — BIIB at a -3.19% CAGR versus GEHC at 3.74%.

Does BIIB or GEHC pay a bigger dividend?

GEHC pays a dividend (0.22% yield), while BIIB has no payments in the available dividend history.

Is BIIB or GEHC more profitable?

BIIB runs the higher net margin — BIIB at 8.39% versus GEHC at 7.86%.

Biogen Inc. (BIIB) vs GE HealthCare Technologies Inc. (GEHC)

A side-by-side comparison of Biogen Inc. and GE HealthCare Technologies Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$33.63B

$227.60HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

GEHC

GE HealthCare Technologies Inc.

$30.10B

$66.63HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — BIIB vs GEHC

growth of $100 · dividends reinvested · last 4y

BIIB -23.9% (-6.6%/yr)GEHC +7.2% (+1.8%/yr)GEHC compounded faster over this window

BIIB GEHC

BIIB vs GEHC: by the numbers

•BIIB is the larger company ($33.63B vs $30.10B market cap).
•GEHC trades at the lower trailing earnings multiple (19.31 vs 40.28 P/E), one valuation lens rather than an overall verdict.
•BIIB converts more revenue to profit (8.39% vs 7.86% net margin).
•GEHC grew revenue faster over the past five years (3.74% vs -3.19% CAGR).
•GEHC pays a dividend (0.22% yield), while BIIB has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIIB	GEHC
P/E ratio	40.28	19.31
Forward P/E	18.33	13.53
P/S ratio	3.38	1.49
P/B ratio	1.78	2.74
EV / EBITDA	N/A	10.64
FCF yield	8.02%	2.97%

Profitability

Metric	BIIB	GEHC
Gross margin	67.71%	42.90%
Operating margin	12.79%	12.70%
Net margin	8.39%	7.86%
ROE	4.43%	14.51%
ROIC	4.28%	6.94%

Dividends

Metric	BIIB	GEHC
Dividend yield	N/A	0.22%
Payout ratio	N/A	4.06%

Growth (annualized)

Metric	BIIB	GEHC
Revenue CAGR (5Y)	-3.19%	3.74%
EPS CAGR (5Y)	-18.67%	0.67%
FCF CAGR (5Y)	-11.63%	1.07%
Total return CAGR (5Y)	-6.25%	N/A

Frequently asked

Which has the lower trailing P/E, BIIB or GEHC?: GEHC has the lower trailing P/E: BIIB trades at 40.28 and GEHC at 19.31. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or GEHC?: Over the past five years, GEHC grew revenue faster — BIIB at a -3.19% CAGR versus GEHC at 3.74%.
Does BIIB or GEHC pay a bigger dividend?: GEHC pays a dividend (0.22% yield), while BIIB has no payments in the available dividend history.
Is BIIB or GEHC more profitable?: BIIB runs the higher net margin — BIIB at 8.39% versus GEHC at 7.86%.

Go deeper

Full BIIB analysis Full GEHC analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio GE HealthCare Technologies P/E ratio GE HealthCare Technologies dividend yield Biogen ROE GE HealthCare Technologies ROE Biogen operating margin GE HealthCare Technologies operating margin Biogen revenue growth GE HealthCare Technologies revenue growth Biogen free cash flow GE HealthCare Technologies free cash flow

Biogen & GE HealthCare Technologies appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.